07/03/2025
7:00 AM | CytoMed Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/23/2025
11:15 PM | CytoMed Therapeutics (Filer)
| Form EFFECT | |
06/23/2025
6:25 AM | CytoMed Therapeutics (Subject)
mDR Ltd (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/13/2025
3:18 PM | CytoMed Therapeutics (Filer)
| Form F-3
Registration statement for securities of certain foreign private issuers | |
05/16/2025
5:30 AM | CytoMed Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/28/2025
3:50 PM | CytoMed Therapeutics (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
04/28/2025
4:00 PM | CytoMed Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/24/2025
11:01 AM | CytoMed Therapeutics (Subject)
mDR Ltd (Filed by)
| Form SCHEDULE 13G/A | |
03/24/2025
11:03 AM | CytoMed Therapeutics (Subject)
mDR Ltd (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/14/2025
6:09 PM | Choo Chee Kong (Filed by)
CytoMed Therapeutics (Subject)
| Form SCHEDULE 13D/A | |
03/04/2025
2:33 PM | 28 Consultants Ltd (Filed by)
CytoMed Therapeutics (Subject)
| Form SCHEDULE 13G | |
01/06/2025
6:40 AM | CytoMed Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/06/2025
6:40 AM | CytoMed Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/05/2024
4:00 PM | CytoMed Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/20/2024
6:00 AM | CytoMed Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/04/2024
11:13 AM | CytoMed Therapeutics (Subject)
mDR Ltd (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/07/2024
6:44 AM | CytoMed Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/03/2024
6:00 AM | CytoMed Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/30/2024
6:00 AM | CytoMed Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
